BillionToOne to Participate in Two Upcoming Investor Conferences
BillionToOne (NASDAQ: BLLN) will participate in two upcoming investor conferences, with fireside chats scheduled for November 10 and 11, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
BillionToOne (NASDAQ: BLLN) will participate in two upcoming investor conferences, with fireside chats scheduled for November 10 and 11, 2026.
The UBS Global Healthcare Conference chat is November 10 at 2:00 PM ET; the Stifel 2026 Healthcare Conference chat is November 11 at 3:20 PM ET. Live and archived webcasts will be available on the Events page of the company's investor relations website.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MENLO PARK, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that the Company will participate in two upcoming investor conferences.
- UBS Global Healthcare Conference 2026
Fireside Chat on Tuesday, November 10th at 2:00 PM ET
- Stifel 2026 Healthcare Conference
Fireside Chat on Wednesday, November 11th at 3:20 PM ET
A live and archived webcast of the events will be available on the “Events” page of BillionToOne’s investor relations website at https://investors.billiontoone.com/.
About BillionToOne
Headquartered in Menlo Park, California, BillionToOne is a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all. The company's patented Quantitative Counting Templates™ (QCT™) molecular counting platform is the only multiplex technology that can accurately count DNA molecules at the single-molecule level. For more information, visit www.billiontoone.com.
Investor Contact
ir@billiontoone.com
Media Contact
rachel@fordhutmanmedia.com
